Showing results (211-220 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|August 21, 2002
TTV viral load as a marker for immune reconstitution after initiation of HAART in HIV-infected patientsChris D Madsen, Jesper Eugen-Olsen, Ole Kirk, et al.
HIV Clinical Trials|August 21, 2002
Comparison of nevirapine- and efavirenz-containing antiretroviral regimens in antiretroviral-naïve patients: a cohort studyPhilip Keiser, Naiel Nassar, Clinton White, et al.
HIV Clinical Trials|August 21, 2002
Salvage treatment with lopinavir/ritonavir (Kaletra) in HIV-infected patients failing all current antiretroviral drug familiesCarmen de Mendoza, Luz Martín-Carbonero, Pablo Barreiro, et al.
HIV Clinical Trials|August 21, 2002
Prevalence of HIV protease mutations on failure of nelfinavir-containing HAART: a retrospective analysis of four clinical studies and two observational cohortsBonaventura Clotet, Lidia Ruiz, Javier Martinez-Picado, et al.
HIV Clinical Trials|December 26, 2002
HIV production from purified monocytes isolated from antiretroviral-naïve and protease inhibitor-treated HIV-1-infected patientsPowel Kazanjian, Donna Adams, Stacey Tate, et al.
HIV Clinical Trials|January 31, 2002
Safety and efficacy of an oral HIV vaccine (V-1 Immunitor) in AIDS patients at various stages of the diseaseVichai Jirathitikal, Aldar S Bourinbaiar
HIV Clinical Trials|January 31, 2002
Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naïve HIV-infected patientsP Clevenbergh, E Cua, E Dam, et al.
HIV Clinical Trials|January 31, 2002
Factors associated with the failure of HIV-positive persons to return for scheduled medical visitsClaudio Arici, Diego Ripamonti, Franco Maggiolo, et al.
HIV Clinical Trials|May 29, 2002
SENC (Spanish efavirenz vs. nevirapine comparison) trial: a randomized, open-label study in HIV-infected naive individualsMarina Núñez, Vincent Soriano, Luz Martín-Carbonero, et al.
HIV Clinical Trials|May 29, 2002
Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores allostimulatory function to accessory cells in patients with AIDSZale P Bernstein, Stephen P Brooks, Asher Chanan-Khan, et al.
Pageof 68